Clinical Trial Update: ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus Infection [Phase 3]

View source ↗

Summary

Phase 3 pharmacokinetic and safety study in pregnant women with HIV completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Infection Due to HIV

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2022-02-18